6 completed, 2 unknown. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Piperacillin: new trials by email Literature Review of Piperacillin trials Research Report on Piperacillin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit Piperacillin/tazobactam or temocillin, Meropenem - Sepsis, Septic Shock | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 600 | 2023-03-11 | 2023-04-18 |
| Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Imipenem, Relebactam, Cilastatin - Bacterial Pneumonia | Phase 3 | Completed | Merck Sharp & Dohme LLC | 537 | 2015-11-24 | 2020-04-16 |
| Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP Meropenem-Vaborbactam, Piperacillin-Tazobactam, Levofloxacin - Urinary Tract Infection Complicated, Acute Pyelonephritis | Phase 3 | Completed | Melinta Therapeutics, Inc. | 550 | 2014-11-20 | 2018-06-11 |
| Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061) Ertapenem sodium, Piperacillin/tazobactam sodium, Piperacillin/tazobactam-matching placebo - Infection; Diabetic Foot | Phase 3 | Completed | Merck Sharp & Dohme LLC | 565 | 2011-09-02 | 2018-08-27 |
| Antibiotic Treatment in Ventilator Associated Tracheobronchitis (VAT) Piperacillin/Tazobactam for 7 days - Tracheobronchitis | Phase 2 / Phase 3 | Unknown | Assaf-Harofeh Medical Center | 100 | 2009-09-01 | 2009-12-09 |
| Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection Moxifloxacin (Avelox, BAY12-8039), Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid - Abscess, Wound Infection | Phase 3 | Completed | Bayer | 813 | 2006-09-01 | 2014-11-07 |
| Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count piperacillin sodium, piperacillin-tazobactam, tazobactam sodium - Bone Marrow Suppression, Fever, Sweats, and Hot Flashes | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 859 | 1997-11-01 | 2012-09-24 |
| Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma Piperacillin/Tazobactam (Tazocin) - Hematologic Neoplasms | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-10-10 |
Infections (3) · Diabetic Foot (2) · Abscess (1) · Blast Crisis (1) · Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Fever (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Hot Flashes (1) · Leukemia (1) · Leukemia, Hairy Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1)
Merck Sharp & Dohme LLC (2) · Assaf-Harofeh Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Bayer (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Melinta Therapeutics, Inc. (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
France (3) · Greece (3) · Israel (3) · United States (3) · Belgium (2) · Bulgaria (2) · Canada (2) · Czechia (2) · Germany (2) · Hungary (2) · Italy (2) · Poland (2) · Romania (2) · Slovakia (2) · Spain (2)
Arie Soroksky, MD (1) · Karen Fusaro (1) · Keith Kaye (1) · Michel P. Glauser, MD (1)
PMID 21896561, PMID 23180507, PMID 26888908, PMID 29486041, PMID 31786695, PMID 32785589, PMID 34704389, PMID 37383243, PMID 41586496, PMID 42743113
2015 (1)